News
MyChesCo on MSN2h
FDA Clears Path for Resumed Use of Elevidys Gene Therapy in Ambulatory DMD PatientsThe U.S. Food and Drug Administration (FDA) has recommended lifting the voluntary clinical hold on Elevidys for ambulatory patients with Duchenne Muscular Dystrophy (DMD), following a thorough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback